United Therapeutics (UTHR) Amortizatization of Intangibles (2009 - 2016)
United Therapeutics (UTHR) reported Amortizatization of Intangibles of -$100000.0 for Q2 2016, up 75.0% on a YoY basis from -$57142.9 in Q3 2015, and up 50.0% sequentially from -$200000.0 in Q1 2016.
United Therapeutics (UTHR) Amortizatization of Intangibles (2009 - 2016) Analysis & Trends
United Therapeutics (UTHR) has 8 years of Amortizatization of Intangibles data on file, last reported at -$100000.0 in Q2 2016.
- For the quarter ending Q2 2016, Amortizatization of Intangibles rose 75.0% year-over-year to -$100000.0; the trailing twelve-month figure through Jun 2016 stood at -$1.0 million (up 71.67% YoY), and the FY2015 full-year result was -$2.1 million, up 59.24% from the prior year.
- Amortizatization of Intangibles climbed to -$100000.0 in Q2 2016, from -$200000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of -$100000.0 in Q2 2016 to a low of -$1.6 million in Q1 2014.
- A 5-year average of -$931555.6 and a median of -$1.0 million in 2013 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles sank 59.44% in 2014 and soared 80.0% in 2016, its largest moves.
- Tracing UTHR's Amortizatization of Intangibles over 5 years: stood at -$1.3 million in 2012, then dropped by 10.3% to -$1.4 million in 2013, then grew by 27.8% to -$1.0 million in 2014, then soared by 74.32% to -$266000.0 in 2015, then surged by 62.41% to -$100000.0 in 2016.
- Business Quant data shows UTHR's Amortizatization of Intangibles at -$100000.0 in Q2 2016, -$200000.0 in Q1 2016, and -$266000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -100,000.00 |
| Jun 30, 2016 | -100,000.00 |
| Mar 31, 2016 | -200,000.00 |
| Mar 31, 2016 | -200,000.00 |
| Dec 31, 2015 | -266,000.00 |
| Dec 31, 2015 | -266,000.00 |
| Sep 30, 2015 | -466,000.00 |
| Sep 30, 2015 | -466,000.00 |
| Jun 30, 2015 | -400,000.00 |
| Jun 30, 2015 | -400,000.00 |
| Mar 31, 2015 | -1.00 Mn |
| Mar 31, 2015 | -1.00 Mn |
| Dec 31, 2014 | -1.04 Mn |
| Dec 31, 2014 | -1.04 Mn |
| Sep 30, 2014 | -1.21 Mn |
| Sep 30, 2014 | -1.21 Mn |
| Jun 30, 2014 | -1.38 Mn |
| Jun 30, 2014 | -1.38 Mn |
| Mar 31, 2014 | -1.60 Mn |
| Mar 31, 2014 | -1.60 Mn |